Saturday, July 12, 2025

Latest

Cresco Labs: Haywood Marginally Revises Estimates Following Cultivate Acquisition

On September 3, Cresco Labs (CSE: CL) announced that they have closed their acquisition of Cultivate, a vertically integrated Massachusetts operator that was acquired for $90 million, plus a potential $68 million earn-out. Cultivate currently operates roughly 42,000 square feet of active canopy with an additional 20,000 square feet of canopy available for build-out. The company has 3 open dispensaries.

Cresco Labs currently has 17 analysts covering the name with an average 12-month price target of $23.97, or a 104% upside. Out of the 17 analysts, 5 have strong buy ratings, 11 have buy ratings and 1 analyst has a hold rating. The street high sits at $34 from Stifel-GMP while the lowest comes in at $18.

Haywood Capital Markets, which has a $12 price target and buy rating, says they have updated their 2021 and 2022 estimates as the acquisition has closed ahead of time. They write, “The expanded Massachusetts operations should position the Company to capitalize on the rapidly growing market.”

Haywood says that the deal when announced represented a 4-4.5x 2021 EV/EBITDA multiple factoring in the $68 million earnouts. Additionally, of the $75 million in shares issued, 68% will have a 4/8/12 month vesting schedule.

They give some background on the Massachusetts market. The market went adult-use back in November of 2018 and has done little over $2 billion in sales since then. With $702 million in sales in 2020 and $844 million year-to-date, that implies a sales run-rate of $1.25 billion and an 80% growth year over year.

Below you can see Haywood’s updated 2021 and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

Hycroft Mining Cash Infusion Not Near Enough To Re-Enter Production, Says BMO

This week, Hycroft Mining (NASDAQ: HYMC), a busted SPAC mining company taken public by Mudrick...

Thursday, March 17, 2022, 04:52:00 PM

Canaccord: “We Expect Kinross’s Trailing 4Q Free Cash Flow To Surpass $800 Million In Q4”

Yesterday, Kinross Gold (TSX: K) released its third quarter financial results. The company reported adjusted...

Thursday, November 5, 2020, 12:27:00 PM

Sundial Growers: Analysts Expect Positive EBITDA For Second Quarter

Sundial Growers Inc. (Nasdaq: SNDL) announced that they will be reporting their second quarter financials...

Wednesday, August 11, 2021, 11:58:00 AM

Barrick Gold Sees Canaccord Lower Price Target On High CAPEX Spend

Last Friday Barrick Gold Corp. (TSX: ABX) had its investor day with sell-side analysts and...

Wednesday, November 23, 2022, 07:24:00 AM

K92 Mining: BMO Expects Sustaining Capital To Be Significantly Higher Than Estimates

K92 Mining Inc. (TSX: KNT) recently reported its second quarter financial results. The company announced...

Monday, September 5, 2022, 05:06:00 PM